Πλοήγηση ανά Θέμα "brentuximab vedotin"
Αποτελέσματα 1-2 από 2
-
Acinetobacter baumannii antibiotic resistance mechanisms
(2021)Acinetobacter baumannii is a Gram-negative ESKAPE microorganism that poses a threat to public health by causing severe and invasive (mostly nosocomial) infections linked with high mortality rates. During the last years, ... -
Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma. The Hellenic experience
(2018)This retrospective study aimed to describe the Hellenic experience on the use of brentuximab vedotin (BV) in relapsed/refractory (R/R) Hodgkin lymphoma (HL) given within its indication. From June 2011 to April 2015, ...